New data from Pitt County Schools shows 81 students in the district are not up to date on their immunizations.

Zanzalintinib and atezolizumab improved overall survival in metastatic colorectal cancer compared to regorafenib, with a median OS of 10.9 vs 9.4 months. The combination showed progression-free ...

Discover ITT Inc.'s growth in revenue and profits, current valuation, and future outlook. Click for why a Hold rating is ...

Exelixis stock dips after Phase 3 data show modest survival gains from zanzalintinib and Tecentriq combo in colorectal cancer ...

CA bayonet connectors are available in 140 different layouts, with one up to 65 pins, an extensive range of backshells and accessories, and with several RoHS-compliant plating options, including VG ...

Detailed price information for Honeywell International Inc (HON-Q) from The Globe and Mail including charting and trades.

Most recurrent ovarian cancer cases arise in patients previously treated with PARP inhibitors making these results noteworthy ...

Exelixis, Inc. (Nasdaq: EXEL) today announced detailed results from STELLAR-303, a global phase 3 pivotal trial evaluating zanzalintinib in combination with atezolizumab (Tecentriq®) versus ...

ITT Tech announced Tuesday morning that it’s closing its for-profit technical schools nationwide, which includes more than 130 campuses, two of which are in Charlotte.

On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 ...

Quiroz took the Silver and Ny Le claimed the Bronze. Derrick Chavarria led the chase group to finish 4th overall in 3:50:40, ...

In the intent-to-treat population, the median progression-free survival (PFS) was 8.77 months with giredestrant plus Afinitor ...